212 related articles for article (PubMed ID: 34364054)
21. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
[TBL] [Abstract][Full Text] [Related]
22. Selective inhibition of monoamine oxidase A by chelerythrine, an isoquinoline alkaloid.
Baek SC; Ryu HW; Kang MG; Lee H; Park D; Cho ML; Oh SR; Kim H
Bioorg Med Chem Lett; 2018 Aug; 28(14):2403-2407. PubMed ID: 29925480
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
Hammuda A; Shalaby R; Rovida S; Edmondson DE; Binda C; Khalil A
Eur J Med Chem; 2016 May; 114():162-9. PubMed ID: 26974383
[TBL] [Abstract][Full Text] [Related]
24. Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
Bonaiuto E; Milelli A; Cozza G; Tumiatti V; Marchetti C; Agostinelli E; Fimognari C; Hrelia P; Minarini A; Di Paolo ML
Eur J Med Chem; 2013; 70():88-101. PubMed ID: 24140951
[TBL] [Abstract][Full Text] [Related]
25. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase.
Engelbrecht I; Petzer JP; Petzer A
Bioorg Med Chem Lett; 2015 May; 25(9):1896-900. PubMed ID: 25857942
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase.
Hitge R; Smit S; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2020 Jun; 30(12):127188. PubMed ID: 32299731
[TBL] [Abstract][Full Text] [Related]
27. 2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors.
Basri R; Fatima S; Jalil S; Imran A; Fatima N; Syed A; Bahkali AH; Iqbal J; Shafiq Z
Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300430. PubMed ID: 37718357
[TBL] [Abstract][Full Text] [Related]
28. Discovery of
Elkamhawy A; Paik S; Kim HJ; Park JH; Londhe AM; Lee K; Pae AN; Park KD; Roh EJ
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1568-1580. PubMed ID: 32752896
[TBL] [Abstract][Full Text] [Related]
29. Enhancing monoamine oxidase B inhibitory activity via chiral fluorination: Structure-activity relationship, biological evaluation, and molecular docking study.
Wang Z; Yi C; Chen K; Wang T; Deng K; Jin C; Hao G
Eur J Med Chem; 2022 Jan; 228():114025. PubMed ID: 34871839
[TBL] [Abstract][Full Text] [Related]
30. A New Potent and Selective Monoamine Oxidase-B Inhibitor with Extended Conjugation in a Chalcone Framework: 1-[4-(Morpholin-4-yl)phenyl]-5-phenylpenta-2,4-dien-1-one.
Maliyakkal N; Eom BH; Heo JH; Abdullah Almoyad MA; Thomas Parambi DG; Gambacorta N; Nicolotti O; Beeran AA; Kim H; Mathew B
ChemMedChem; 2020 Sep; 15(17):1629-1633. PubMed ID: 32583952
[TBL] [Abstract][Full Text] [Related]
31. Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors.
Sağlık BN; Cebeci O; Acar Çevik U; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2020 Sep; 25(18):. PubMed ID: 32971892
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents.
Agrawal N; Mishra P
Comput Biol Chem; 2019 Apr; 79():63-72. PubMed ID: 30731360
[TBL] [Abstract][Full Text] [Related]
33. Imidazole bearing chalcones as a new class of monoamine oxidase inhibitors.
Sasidharan R; Baek SC; Sreedharannair Leelabaiamma M; Kim H; Mathew B
Biomed Pharmacother; 2018 Oct; 106():8-13. PubMed ID: 29940538
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and evaluation of 2-(indolylmethylidene)-2,3-dihydro-1-benzofuran-3-one and 2-(indolyl)-4H-chromen-4-one derivatives as novel monoamine oxidases inhibitors.
Takao K; U S; Kamauchi H; Sugita Y
Bioorg Chem; 2019 Jun; 87():594-600. PubMed ID: 30933784
[TBL] [Abstract][Full Text] [Related]
35. 2-Phenyloxazole-4-carboxamide as a Scaffold for Selective Inhibition of Human Monoamine Oxidase B.
Di Paolo ML; Christodoulou MS; Calogero AM; Pinzi L; Rastelli G; Passarella D; Cappelletti G; Dalla Via L
ChemMedChem; 2019 Sep; 14(18):1641-1652. PubMed ID: 31322823
[TBL] [Abstract][Full Text] [Related]
36. 2-Styrylchromone derivatives as potent and selective monoamine oxidase B inhibitors.
Takao K; Endo S; Nagai J; Kamauchi H; Takemura Y; Uesawa Y; Sugita Y
Bioorg Chem; 2019 Nov; 92():103285. PubMed ID: 31561103
[TBL] [Abstract][Full Text] [Related]
37. Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors.
Çeçen M; Oh JM; Özdemir Z; Büyüktuncel SE; Uysal M; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Mathew B; Kim H
Molecules; 2020 Nov; 25(22):. PubMed ID: 33212876
[TBL] [Abstract][Full Text] [Related]
38. Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition.
Khan NA; Khan I; Abid SMA; Zaib S; Ibrar A; Andleeb H; Hameed S; Iqbal J
Med Chem; 2018; 14(1):74-85. PubMed ID: 28545383
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and evaluation of 1, 4-benzodioxan-substituted chalcones as selective and reversible inhibitors of human monoamine oxidase B.
Kong Z; Sun D; Jiang Y; Hu Y
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1513-1523. PubMed ID: 32705910
[TBL] [Abstract][Full Text] [Related]
40. Monoamine oxidase inhibitory activity of 2-aryl-4H-chromen-4-ones.
Nayak BV; Ciftci-Yabanoglu S; Bhakat S; Timiri AK; Sinha BN; Ucar G; Soliman ME; Jayaprakash V
Bioorg Chem; 2015 Feb; 58():72-80. PubMed ID: 25506816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
